[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
July 1997

Comparison of Carotid Endarterectomy Outcomes From Randomized Controlled Trials and Medicare Administrative Databases

Author Affiliations

From the Williamson Institute for Health Studies, Medical College of Virginia, Virginia Commonwealth University, Richmond.

Arch Neurol. 1997;54(7):826-832. doi:10.1001/archneur.1997.00550190018009
Abstract

Objective:  To compare the characteristics and outcomes demonstrated for participants in randomized controlled trials of carotid endarterectomy with those of the Medicare patient population who received the procedure in 1989.

Design:  Historical cohort study using Medicare claims data.

Setting:  Medicare beneficiary population aged 65 years and older.

Patients:  Medicare patients 65 years and older who received carotid endarterectomy during 1989.

Main Outcome Measures:  Perioperative mortality rate and occurrence of transient ischemic attack, stroke, and death within 2 years of surgery.

Results:  The risk for death within 2 years of the procedure was substantially higher among Medicare patients who received surgery in hospitals with perioperative mortality rates greater than rates demonstrated in the trials (odds ratio, 1.36; 95% confidence interval, 1.29-1.44) and among those with comorbidity that exceeded trial participation criteria (odds ratio, 1.72; 95% confidence interval, 1.64-1.84).

Conclusions:  Although carotid endarterectomy trials demonstrate the efficacy of the procedure, this evidence only applies to patients and hospitals with characteristics comparable to those of the trial participants. The importance of this consideration is demonstrated by the substantially higher odds of death experienced among Medicare patients receiving the procedure who had a level of comorbidity that exceeded that of the trial participants or who received their surgery in a hospital with a perioperative mortality rate that exceeded the experience of the hospitals in the trials.

×